{"pmid":32422384,"title":"Diagnosis and treatment of coronavirus disease 2019 (COVID-19): Laboratory, PCR, and chest CT imaging findings.","text":["Diagnosis and treatment of coronavirus disease 2019 (COVID-19): Laboratory, PCR, and chest CT imaging findings.","Since December 2019, more than 3 million cases of coronavirus disease 2019 (COVID-19) and about 200,000 deaths have been reported worldwide. The outbreak of this novel disease has become a global health emergency and continues to rapidly spread around the world. Based on the clinical data, approved cases are divided into four classes including mild, moderate, severe, and critical. About 5% of cases were considered critically ill and 14% were considered to have the severe classification of the disease. In China, the fatality rate of this infection was about 4%. This review focuses on currently available information on the etiology, clinical symptoms, diagnosis, and mechanism of action of COVID-19. Furthermore, we present an overview of diagnostic approaches and treatment of this disease according to available findings. This review paper will help the physician to diagnose and successfully treat COVID-19.","Int J Surg","Abbasi-Oshaghi, Ebrahim","Mirzaei, Fatemeh","Farahani, Farhad","Khodadadi, Iraj","Tayebinia, Heidar","32422384"],"abstract":["Since December 2019, more than 3 million cases of coronavirus disease 2019 (COVID-19) and about 200,000 deaths have been reported worldwide. The outbreak of this novel disease has become a global health emergency and continues to rapidly spread around the world. Based on the clinical data, approved cases are divided into four classes including mild, moderate, severe, and critical. About 5% of cases were considered critically ill and 14% were considered to have the severe classification of the disease. In China, the fatality rate of this infection was about 4%. This review focuses on currently available information on the etiology, clinical symptoms, diagnosis, and mechanism of action of COVID-19. Furthermore, we present an overview of diagnostic approaches and treatment of this disease according to available findings. This review paper will help the physician to diagnose and successfully treat COVID-19."],"journal":"Int J Surg","authors":["Abbasi-Oshaghi, Ebrahim","Mirzaei, Fatemeh","Farahani, Farhad","Khodadadi, Iraj","Tayebinia, Heidar"],"date":"2020-05-19T11:00:00Z","year":2020,"_id":"32422384","source":"PubMed","week":"202021|May 18 - May 24","doi":"10.1016/j.ijsu.2020.05.018","keywords":["covid-19 vaccine","chloroquine","coronavirus","coronavirus infection","respiratory tract infections","viral pneumonia"],"locations":["China"],"countries":["China"],"countries_codes":["CHN|China"],"topics":["Diagnosis"],"weight":1,"_version_":1667159284417298432,"score":9.490897,"similar":[{"pmid":32391664,"title":"[CT imaging features of patients with different clinical types of COVID-19].","text":["[CT imaging features of patients with different clinical types of COVID-19].","OBJECTIVE: To investigate the CT findings of patients with different clinical types of coronavirus disease 2019 (COVID-19). METHODS: A total of 67 patients diagnosed as COVID-19 by nucleic acid testing were collected and divided into 4 groups according to the clinical stages based on Diagnosis and treatment of novel coronavirus pneumonia (trial version 6). The CT imaging characteristics were analyzed among patients with different clinical types. RESULTS: Among 67 patients, 3(4.5%) were mild, 35 (52.2%) were moderate, 22 (32.8%) were severe, and 7(10.4%) were critical ill. No significant abnormality in chest CT imaging in mild patients. The 35 cases of moderate type included 3 (8.6%) single lesions, the 22 cases of severe cases included 1 (4.5%) single lesion and the rest cases were with multiple lesions. CT images of moderate patients were mainly manifested by solid plaque shadow and halo sign (18/35, 51.4%); while fibrous strip shadow with ground glass shadow was more frequent in severe cases (7/22, 31.8%). Consolidation shadow as the main lesion was observed in 7 cases, and all of them were severe or critical ill patients. CONCLUSIONS: CT images of patients with different clinical types of COVID-19 have characteristic manifestations, and solid shadow may predict severe and critical illness.","Zhejiang Da Xue Xue Bao Yi Xue Ban","Zhong, Qi","Li, Zhi","Shen, Xiaoyong","Xu, Kaijin","Shen, Yihong","Fang, Qiang","Chen, Feng","Liang, Tingbo","32391664"],"abstract":["OBJECTIVE: To investigate the CT findings of patients with different clinical types of coronavirus disease 2019 (COVID-19). METHODS: A total of 67 patients diagnosed as COVID-19 by nucleic acid testing were collected and divided into 4 groups according to the clinical stages based on Diagnosis and treatment of novel coronavirus pneumonia (trial version 6). The CT imaging characteristics were analyzed among patients with different clinical types. RESULTS: Among 67 patients, 3(4.5%) were mild, 35 (52.2%) were moderate, 22 (32.8%) were severe, and 7(10.4%) were critical ill. No significant abnormality in chest CT imaging in mild patients. The 35 cases of moderate type included 3 (8.6%) single lesions, the 22 cases of severe cases included 1 (4.5%) single lesion and the rest cases were with multiple lesions. CT images of moderate patients were mainly manifested by solid plaque shadow and halo sign (18/35, 51.4%); while fibrous strip shadow with ground glass shadow was more frequent in severe cases (7/22, 31.8%). Consolidation shadow as the main lesion was observed in 7 cases, and all of them were severe or critical ill patients. CONCLUSIONS: CT images of patients with different clinical types of COVID-19 have characteristic manifestations, and solid shadow may predict severe and critical illness."],"journal":"Zhejiang Da Xue Xue Bao Yi Xue Ban","authors":["Zhong, Qi","Li, Zhi","Shen, Xiaoyong","Xu, Kaijin","Shen, Yihong","Fang, Qiang","Chen, Feng","Liang, Tingbo"],"date":"2020-05-12T11:00:00Z","year":2020,"_id":"32391664","source":"PubMed","week":"202020|May 11 - May 17","topics":["Diagnosis"],"weight":1,"_version_":1666528580012605441,"score":125.39004},{"pmid":32426751,"pmcid":"PMC7188425","title":"The Clinical Presentation and Immunology of Viral Pneumonia and Implications for Management of Coronavirus Disease 2019.","text":["The Clinical Presentation and Immunology of Viral Pneumonia and Implications for Management of Coronavirus Disease 2019.","This review will briefly examine the clinical presentation and important immunology of viral pneumonia with a focus on severe acute respiratory syndrome coronavirus 2 (coronavirus disease 2019). Data Sources Study Selection Data Extraction and Data Synthesis: The most relevant, original and review literature were assessed for inclusion in this review. Sources included the Centers for Disease Control and Prevention, World Health Organization, and PubMed. Conclusions: Pneumonia is a leading cause of hospitalization and death worldwide, with viral etiologies being very common. Given the rapidly emerging pandemic associated with the novel severe acute respiratory syndrome coronavirus 2 causing coronavirus disease 2019, it is important to review the clinical presentation and immunologic changes associated with viral pneumonia. Symptoms of viral pneumonia include common respiratory tract infection symptoms of cough, fever, and shortness of breath. Immunologic changes include up-regulation of airway pro-inflammatory cytokines and pathogen- and damage-associated molecular patterns contributing to cytokine and genomic changes. Coronavirus disease 2019 clinical presentation is typical of viral pneumonia with an increased prevalence of early pulmonary infiltrates and lymphopenia. Principles of early coronavirus disease 2019 management and isolation as well as potential therapeutic approaches to the emerging pandemic are discussed.","Crit Care Explor","Darden, Dijoia B","Hawkins, Russell B","Larson, Shawn D","Iovine, Nicole M","Prough, Donald S","Efron, Philip A","32426751"],"abstract":["This review will briefly examine the clinical presentation and important immunology of viral pneumonia with a focus on severe acute respiratory syndrome coronavirus 2 (coronavirus disease 2019). Data Sources Study Selection Data Extraction and Data Synthesis: The most relevant, original and review literature were assessed for inclusion in this review. Sources included the Centers for Disease Control and Prevention, World Health Organization, and PubMed. Conclusions: Pneumonia is a leading cause of hospitalization and death worldwide, with viral etiologies being very common. Given the rapidly emerging pandemic associated with the novel severe acute respiratory syndrome coronavirus 2 causing coronavirus disease 2019, it is important to review the clinical presentation and immunologic changes associated with viral pneumonia. Symptoms of viral pneumonia include common respiratory tract infection symptoms of cough, fever, and shortness of breath. Immunologic changes include up-regulation of airway pro-inflammatory cytokines and pathogen- and damage-associated molecular patterns contributing to cytokine and genomic changes. Coronavirus disease 2019 clinical presentation is typical of viral pneumonia with an increased prevalence of early pulmonary infiltrates and lymphopenia. Principles of early coronavirus disease 2019 management and isolation as well as potential therapeutic approaches to the emerging pandemic are discussed."],"journal":"Crit Care Explor","authors":["Darden, Dijoia B","Hawkins, Russell B","Larson, Shawn D","Iovine, Nicole M","Prough, Donald S","Efron, Philip A"],"date":"2020-05-20T11:00:00Z","year":2020,"_id":"32426751","source":"PubMed","week":"202021|May 18 - May 24","doi":"10.1097/CCE.0000000000000109","keywords":["coronavirus","immunology","influenza virus","severe acute respiratory syndrome","viral pneumonia"],"topics":["Treatment","Mechanism","Diagnosis"],"weight":1,"_version_":1667252837838487552,"score":123.81174},{"pmid":32207591,"title":"[CT imaging features of patients with different clinical types of coronavirus disease 2019 (COVID-19)].","text":["[CT imaging features of patients with different clinical types of coronavirus disease 2019 (COVID-19)].","OBJECTIVE: To analyze the CT findings of patients with different clinical types of coronavirus disease 2019 (COVID-19). METHODS: A total of 67 patients diagnosed as COVID-19 by nucleic acid testing were included and divided into 4 groups according to the clinical staging based on Diagnosis and treatment of novel coronavirus pneumonia (Trial version 6). The CT imaging characteristics were analyzed among patients with different clinical types. RESULTS: Among 67 patients, 3 (4.5%) were mild cases, 35 (52.2%) were ordinary cases, 22 (32.8%) were severe cases, and 7 (10.4%) were critically ill. There were no abnormal CT findings in mild cases. In 35 ordinary cases, there were single lesions in 3 cases (8.6%) and multiple lesions in 33 cases (91.4%), while in severe case 1 case had single lesion (4.5%) and 21 had multiple lesions (95.5%). CT images of ordinary patients were mainly manifested as solid plaque shadow and halo sign (18/35, 51.4%); while fibrous strip shadow with ground glass shadow was more frequent in severe cases (7/22, 31.8%). Consolidation shadow as the main lesion was observed in 7 cases, and all of them were severe or critical ill patients. CONCLUSIONS: CT images in patients with different clinical types of COVID-19 have characteristic manifestations, and solid shadow may predict severe and critical illness.","Zhejiang Da Xue Xue Bao Yi Xue Ban","Zhong, Qi","Li, Zhi","Shen, Xiaoyong","Xu, Kaijin","Shen, Yihong","Fang, Qiang","Chen, Feng","Liang, Tingbo","32207591"],"abstract":["OBJECTIVE: To analyze the CT findings of patients with different clinical types of coronavirus disease 2019 (COVID-19). METHODS: A total of 67 patients diagnosed as COVID-19 by nucleic acid testing were included and divided into 4 groups according to the clinical staging based on Diagnosis and treatment of novel coronavirus pneumonia (Trial version 6). The CT imaging characteristics were analyzed among patients with different clinical types. RESULTS: Among 67 patients, 3 (4.5%) were mild cases, 35 (52.2%) were ordinary cases, 22 (32.8%) were severe cases, and 7 (10.4%) were critically ill. There were no abnormal CT findings in mild cases. In 35 ordinary cases, there were single lesions in 3 cases (8.6%) and multiple lesions in 33 cases (91.4%), while in severe case 1 case had single lesion (4.5%) and 21 had multiple lesions (95.5%). CT images of ordinary patients were mainly manifested as solid plaque shadow and halo sign (18/35, 51.4%); while fibrous strip shadow with ground glass shadow was more frequent in severe cases (7/22, 31.8%). Consolidation shadow as the main lesion was observed in 7 cases, and all of them were severe or critical ill patients. CONCLUSIONS: CT images in patients with different clinical types of COVID-19 have characteristic manifestations, and solid shadow may predict severe and critical illness."],"journal":"Zhejiang Da Xue Xue Bao Yi Xue Ban","authors":["Zhong, Qi","Li, Zhi","Shen, Xiaoyong","Xu, Kaijin","Shen, Yihong","Fang, Qiang","Chen, Feng","Liang, Tingbo"],"date":"2020-03-25T11:00:00Z","year":2020,"_id":"32207591","source":"PubMed","week":"202013|Mar 23 - Mar 29","topics":["Diagnosis"],"weight":1,"_version_":1666138490147962881,"score":118.49654},{"pmid":32466458,"title":"Challenges in Laboratory Diagnosis of the Novel Coronavirus SARS-CoV-2.","text":["Challenges in Laboratory Diagnosis of the Novel Coronavirus SARS-CoV-2.","The recent outbreak of the Coronavirus disease 2019 (COVID-19) has quickly spread worldwide since its discovery in Wuhan city, China in December 2019. A comprehensive strategy, including surveillance, diagnostics, research, clinical treatment, and development of vaccines, is urgently needed to win the battle against COVID-19. The past three unprecedented outbreaks of emerging human coronavirus infections at the beginning of the 21st century have highlighted the importance of readily available, accurate, and rapid diagnostic technologies to contain emerging and re-emerging pandemics. Real-time reverse transcriptase-polymerase chain reaction (rRT-PCR) based assays performed on respiratory specimens remain the gold standard for COVID-19 diagnostics. However, point-of-care technologies and serologic immunoassays are rapidly emerging with high sensitivity and specificity as well. Even though excellent techniques are available for the diagnosis of symptomatic patients with COVID-19 in well-equipped laboratories; critical gaps still remain in screening asymptomatic people who are in the incubation phase of the virus, as well as in the accurate determination of live viral shedding during convalescence to inform decisions for ending isolation. This review article aims to discuss the currently available laboratory methods and surveillance technologies available for the detection of COVID-19, their performance characteristics and highlight the gaps in current diagnostic capacity, and finally, propose potential solutions. We also summarize the specifications of the majority of the available commercial kits (PCR, EIA, and POC) for laboratory diagnosis of COVID-19.","Viruses","Younes, Nadin","Al-Sadeq, Duaa W","Al-Jighefee, Hadeel","Younes, Salma","Al-Jamal, Ola","Daas, Hanin I","Yassine, Hadi M","Nasrallah, Gheyath K","32466458"],"abstract":["The recent outbreak of the Coronavirus disease 2019 (COVID-19) has quickly spread worldwide since its discovery in Wuhan city, China in December 2019. A comprehensive strategy, including surveillance, diagnostics, research, clinical treatment, and development of vaccines, is urgently needed to win the battle against COVID-19. The past three unprecedented outbreaks of emerging human coronavirus infections at the beginning of the 21st century have highlighted the importance of readily available, accurate, and rapid diagnostic technologies to contain emerging and re-emerging pandemics. Real-time reverse transcriptase-polymerase chain reaction (rRT-PCR) based assays performed on respiratory specimens remain the gold standard for COVID-19 diagnostics. However, point-of-care technologies and serologic immunoassays are rapidly emerging with high sensitivity and specificity as well. Even though excellent techniques are available for the diagnosis of symptomatic patients with COVID-19 in well-equipped laboratories; critical gaps still remain in screening asymptomatic people who are in the incubation phase of the virus, as well as in the accurate determination of live viral shedding during convalescence to inform decisions for ending isolation. This review article aims to discuss the currently available laboratory methods and surveillance technologies available for the detection of COVID-19, their performance characteristics and highlight the gaps in current diagnostic capacity, and finally, propose potential solutions. We also summarize the specifications of the majority of the available commercial kits (PCR, EIA, and POC) for laboratory diagnosis of COVID-19."],"journal":"Viruses","authors":["Younes, Nadin","Al-Sadeq, Duaa W","Al-Jighefee, Hadeel","Younes, Salma","Al-Jamal, Ola","Daas, Hanin I","Yassine, Hadi M","Nasrallah, Gheyath K"],"date":"2020-05-30T11:00:00Z","year":2020,"_id":"32466458","source":"PubMed","week":"202022|May 25 - May 31","doi":"10.3390/v12060582","keywords":["covid-19","sars-cov-2","diagnostic challenges","molecular testing","serology","viruses"],"locations":["Wuhan","China"],"countries":["China"],"countries_codes":["CHN|China"],"topics":["Diagnosis","Prevention"],"weight":1,"_version_":1668420887292936193,"score":117.53721},{"pmid":32352917,"title":"Radiological approach to COVID-19 pneumonia with an emphasis on chest CT.","text":["Radiological approach to COVID-19 pneumonia with an emphasis on chest CT.","Coronavirus disease 2019 (COVID-19) has recently become a worldwide outbreak with several millions of people infected and more than 160.000 deaths. A fast and accurate diagnosis in this outbreak is critical to isolate and treat patients. Radiology plays an important role in the diagnosis and management of the patients. Among various imaging modalities, chest CT has received attention with its higher sensitivity and specificity rates. Shortcomings of the real-time reverse transcriptase-polymerase chain reaction test, including inappropriate sample collection and analysis methods, initial false negative results, and limited availability has led to widespread use of chest CT in the diagnostic algorithm. This review summarizes the role of radiology in COVID-19 pneumonia, diagnostic accuracy of imaging, and chest CT findings of the disease.","Diagn Interv Radiol","Guneyli, Serkan","Atceken, Zeynep","Dogan, Hakan","Altinmakas, Emre","Atasoy, Kayhan Cetin","32352917"],"abstract":["Coronavirus disease 2019 (COVID-19) has recently become a worldwide outbreak with several millions of people infected and more than 160.000 deaths. A fast and accurate diagnosis in this outbreak is critical to isolate and treat patients. Radiology plays an important role in the diagnosis and management of the patients. Among various imaging modalities, chest CT has received attention with its higher sensitivity and specificity rates. Shortcomings of the real-time reverse transcriptase-polymerase chain reaction test, including inappropriate sample collection and analysis methods, initial false negative results, and limited availability has led to widespread use of chest CT in the diagnostic algorithm. This review summarizes the role of radiology in COVID-19 pneumonia, diagnostic accuracy of imaging, and chest CT findings of the disease."],"journal":"Diagn Interv Radiol","authors":["Guneyli, Serkan","Atceken, Zeynep","Dogan, Hakan","Altinmakas, Emre","Atasoy, Kayhan Cetin"],"date":"2020-05-01T11:00:00Z","year":2020,"_id":"32352917","source":"PubMed","week":"202018|Apr 27 - May 03","doi":"10.5152/dir.2020.20260","topics":["Diagnosis"],"weight":1,"_version_":1666138495632015360,"score":117.317085}]}